![](/img/cover-not-exists.png)
Incorporating acalabrutinib, a selective nextâgeneration Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies
Danilov, Alexey V., Persky, Daniel O.Journal:
British Journal of Haematology
DOI:
10.1111/bjh.17184
Date:
November, 2020
File:
PDF, 332 KB
2020